A number of other research firms also recently commented on OHI. Mizuho boosted their target price on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a research report on Thursday, December 5th. BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price on the stock in a research report on Thursday, October 31st. Royal Bank of Canada boosted their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research report on Monday, November 11th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a "buy" rating and a $45.00 price target for the company. Finally, BMO Capital Markets raised Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price target for the company in a report on Monday, December 9th. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Omega Healthcare Investors currently has an average rating of "Moderate Buy" and an average price target of $41.67.
Check Out Our Latest Analysis on Omega Healthcare Investors
Shares of OHI traded down $0.34 during midday trading on Friday, hitting $37.72. The company had a trading volume of 828,972 shares, compared to its average volume of 1,879,517. The company's 50-day simple moving average is $38.06 and its 200-day simple moving average is $39.06. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The firm has a market capitalization of $10.18 billion, a P/E ratio of 27.74, a P/E/G ratio of 1.08 and a beta of 0.99. Omega Healthcare Investors has a 1 year low of $29.17 and a 1 year high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 EPS for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 8.83% and a net margin of 34.41%. As a group, sell-side analysts expect that Omega Healthcare Investors will post 2.72 EPS for the current year.
A number of large investors have recently modified their holdings of the company. Daiwa Securities Group Inc. grew its stake in shares of Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after buying an additional 3,003,845 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust's stock valued at $67,642,000 after buying an additional 1,274,238 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at about $20,058,000. FMR LLC grew its stake in Omega Healthcare Investors by 9.9% during the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust's stock valued at $171,625,000 after purchasing an additional 380,626 shares in the last quarter. Finally, Franklin Resources Inc. grew its stake in Omega Healthcare Investors by 441.4% during the 3rd quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust's stock valued at $17,177,000 after purchasing an additional 350,570 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.